Dendrogenix is a biopharmaceutical company based in Liège (Belgium) dedicated to developing first in class molecules named "Dendrogenins" addressing important medical needs in the field of neurodegenerative diseases, in particular in Hearing Loss indication, and in the field of Oncology.
Company Details
- Employees
- 11
- Founded
- -
- Address
- Avenue De L'hôpital 11, Liège,région Wallonne 4000,belgium
- Industry
- Biotechnology
- Website
- http://www.dendrogenix.com
- Keywords
- biotechnologie, surdité, maladies neurodégénératives, oncologie, chimie médicinale, hearingloss, deafness, stroke.
- HQ
- Liège, Région wallonne
Dendrogenix Questions
Dendrogenix's website is http://www.dendrogenix.com
Dendrogenix's LinkedIn profile is https://be.linkedin.com/company/dendrogenix
Dendrogenix has
11 employees.
View email and phone details for 11
employees at Dendrogenix.
Dendrogenix's industry is
Biotechnology
Dendrogenix's top competitors are
Livedrop Bio,
Trasis,
Inokura,
Eyed Pharma,
Artialis,
Theratrame,
Kitozyme,
Kaplab By Chu Liege,
Unisensor,
Epics Therapeutics.
Dendrogenix's categories are Biotechnology
Dendrogenix's founding year is 2018
